BRIEF-EU and AstraZeneca Agree On COVID-19 Vaccine Supply And On Ending Litigation

* EC - AGREEMENT WITH AZ WILL BRING THE TOTAL NUMBER OF DOSES DELIVERED TO 300 MILLION DOSES AS AGREED UNDER THE CONTRACT. * EC - MEMBER STATES WILL BE PROVIDED WITH REGULAR DELIVERY SCHEDULES AND CAPPED REBATES WILL APPLY IN THE EVENT OF ANY DELAYED DOSES.

European Commission: * EC: EU AND ASTRAZENECA HAVE REACHED AN AGREEMENT WHICH WILL SECURE THE DELIVERY OF THE REMAINING COVID-19 VACCINE DOSES TO MEMBER STATES

* EC - AGREEMENT WILL ALSO END THE PENDING LITIGATION BEFORE THE BRUSSELS COURT. * EC - AGREEMENT WITH AZ WILL BRING THE TOTAL NUMBER OF DOSES DELIVERED TO 300 MILLION DOSES AS AGREED UNDER THE CONTRACT.

* EC - MEMBER STATES WILL BE PROVIDED WITH REGULAR DELIVERY SCHEDULES AND CAPPED REBATES WILL APPLY IN THE EVENT OF ANY DELAYED DOSES. * EC: SETTLEMENT PROVIDES FOR FIRM COMMITMENT BY ASTRAZENECA TO DELIVER, IN ADDITION TO AROUND 100 MILLION DOSES DELIVERED UNTIL END OF Q2, 135 MILLION DOSES BY END OF 2021

* EC: SETTLEMENT AGREEMENT ALSO PROVIDES FOR FIRM COMMITMENT BY ASTRAZENECA TO DELIVER TO REMAINING DOSES (65 MILLION) BY END OF MARCH 2022 Further company coverage: